Thyroid Cancer with Bone Metastases: A Study on Prognostic Factors
Author Information
Author(s): Wu Karl, Hou Shen-Mou, Huang Tien-Shang, Yang Rong-Sen
Primary Institution: National Taiwan University Hospital
Hypothesis
What are the prognostic factors affecting survival in patients with thyroid carcinoma and bone metastases?
Conclusion
Both tumor type and hypercalcemia are significant prognostic factors for survival time in patients with thyroid carcinoma and bone metastases.
Supporting Evidence
- The incidence of bone metastasis from thyroid carcinomas in this series was 5.0%.
- The 5-year survival rate was 79.4% and the 10-year survival rate was 52.9%.
- Patients with papillary and follicular cancers survived significantly longer than those with anaplastic and medullary cancers.
- Twelve patients had hypercalcemic episodes, which were associated with worse survival outcomes.
Takeaway
This study looked at patients with thyroid cancer that spread to their bones and found that the type of cancer and high calcium levels in the blood can affect how long they live.
Methodology
The study reviewed medical records of 44 patients with thyroid carcinoma and bone metastases, analyzing demographic data, clinical manifestations, and treatment outcomes using Kaplan-Meier survival analysis.
Potential Biases
The data was collected from a tertiary referral center, which may not represent the general population.
Limitations
The study's findings may not be generalizable due to its retrospective nature and the limited number of patients with certain cancer types.
Participant Demographics
75% female, 25% male; age range from 12 to 85 years, mean age 62.1 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website